Instrument Inactif

Communiqués LifeAssays AB (publ)

Actions

LifeAssays : Styrelsen i LifeAssays AB (publ) meddelar att bolagets rörelsekapital är säkerställt för minst 12 månader	17/08/20	PU
LifeAssays : fortsätter sin struktureringsplan och har genomför en kvittningsemission av aktier om ca 2,5 MSEK	14/08/20	PU
LifeAssays publ : Aegirbio has completed its first sale	14/04/20	AQ
New business area: Aegirbio's technology can demonstrate immunity to Corona virus	09/04/20	AQ
LifeAssays publ : Abreos gets Grant of 850 000 USD for monitoring of Crohns disease	25/02/20	AQ
LifeAssays publ : ® collaboration partner Abreos and the FDA in collaboration to develop method for measuring the concentration of active drug in blood.	29/01/20	AQ
LifeAssays publ : Abreos Biosciences and LifeAssays® AB form a jointly owned company and enter into associated license agreements. The new company is targeting revenue as early as Q1 2020	27/11/19	AQ

Aucun résultat pour cette recherche